Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink™) in cardiac surgery

Canadian Journal of Anesthesia

Volumn 48, Issue 4 SUPPL., 2001, Pages

  Cheng, Davy C H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; AF 0144; ALDEHYDE DERIVATIVE; DIASPIRIN CROSSLINKED HEMOGLOBIN; FLUOROCARBON; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN BASED OXYGEN CARRIER 201; NITRIC OXIDE; O RAFFINOSE CROSSLINKED HEMOGLOBIN; PERFLUOROOCTYL BROMIDE; POLY STROMA FREE HEMOGLOBIN; POLYMERIZED HEMOGLOBIN; RAFFINOSE; TETRAMER; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ANEMIA; ARTICLE; BINDING AFFINITY; BLOOD AUTOTRANSFUSION; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COVALENT BOND; CROSS LINKING; DATA ANALYSIS; DRUG BINDING; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; DRUG TOLERABILITY; ERYTHROCYTE; ESOPHAGUS DISEASE; HEART SURGERY; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; OXIDATION; OXYGEN THERAPY; PRIORITY JOURNAL; TIME; VIRUS;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; CORONARY ARTERY BYPASS; HEMOGLOBINS; HUMANS; RAFFINOSE; RESEARCH DESIGN;

EID: 0035008248     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Spahn DR, van Brempt R, Theilmeier G, et al., and the European Perflubron Emulsion Study Group. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthesiology 1999; 91: 1195-208.
2. LaMuraglia GM, O'Hara PJ, Baker WH, et al. The reduction of allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000; 31: 299-308.
3. Lamy ML, Daily EK, Brichant J-F, et al., for the DCLHb Cardiac Surgery Trial Collaborative Group. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 2000; 92: 646-56.
4. Hughes G Jr, Jacobs E Jr, Francom S, and the Hemopure Surgical Study Group. A Novel hemoglobin-based oxygen carrier accelerates erythropoiesis in surgical patients. Crit Care Med 1996; 24(Suppl.): A36 (abstract).
5. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187: 113-22.
6. Sloan EP, Koenigsberg M, Gens D, for the DCLHb Traumatic Hemorrhage Shock Study Group. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagjc shock. A randomized controlled efficacy trial. JAMA 1999; 282: 1857-64.
7. Mazer D. Review of clinical trials of oxygen therapeutics. Transfusion Alternative in Transfusion Medicine (TATM) 2000; SI: 27-31.
8. Hardy J-F, Carmichael FJL, Biro G, Martineau R, Chelly J. Hemoglobin replacement therapy with Hemolink™ in patients undergoing CABG in conjunction with intraoperative autologous donation (IAD). Anesthesiology 2000; 93: A186 (abstract).
9. th World Congress of the International Society of Hematology. 2000; 14 (abstract).
10. th World Congress of the International Society of Hematology. 2000; 132 (abstract).
11. Finegan BA, Guenther CR, Hill SE, Biro GP, Carmichael L. O-raffinose crosslinked human hemoglobin (Hemolink): effect on clinical chemistry in patients undergoing coronary artery bypass (CABG) surgery. Anesthesiology 2000; 93: A184 (abstract).
12. Paajanen H, Nuutinen P, Harmoinen A, et al. Hyperamylasemia after cardiopulmonary bypass: pancreatic cellular injury or impaired renal excretion of amylase? Surgery 1998; 123: 504-10.
13. Fernandez-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382-7.
14. Cheng DCH, Ralph-Edwards A, Mazer CD, Carmichael FJL, Biro GP. The hemodynamic effects of the red cell substitute Hemolink™ (o-raffinose cross-linked human hemoglobin) on vital signs in patients undergoing CABG surgery. Anesthesiology 2000; 93: A180 (abstract).
15. Schreiber GB, Busch MP, Kleinman SH, Korditz JJ. The risk of transfusion-transmitted viral infections. The retrovir epidemiology donor study. N Engl J Med 1996; 334: 1685-90.
16. Lee DH, Paling JE, Blajchman MA. A new tool for communicating transfusion risk information. Transfusion 1998; 38: 184-8.